Commission Implementing Regulation (EU) 2020/1712 of 16 November 2020 amending Regulation (EU) No 37/2010 to classify the substance lidocaine as regards its maximum residue limit (Text with EEA relevance)

• CELEX: Implementing Regulation (EU) 2020/1712
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance ‘lidocaine’ is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRLs

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Lidocaine

NOT APPLICABLE

Equidae

No MRL required

NOT APPLICABLE

For local/regional anaesthesia only.

Local anaesthetic’

Porcine

For use in piglets up to 7 days of age only.

For cutaneous and epilesional use only.

Lidocaine

Bovine

150 μg/kg

200 μg/kg

1 μg/kg

200 μg/kg

30 μg/kg

Muscle

Fat

Liver

Kidney

Milk

NOT APPLICABLE